In a mouse model, it has been shown that tumor growth and inflammation of the metastatic niche can be inhibited by dual inhibition of IGF-1R and the STAT3 pathway by the aforementioned NT157, resulting in significantly smaller sizes of both primary and metastatic tumors [199]. This evidence concerns the gene IGF1R and neoplasm.